Literature DB >> 24486071

Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.

Tanya M Laidlaw1, Anya J Cutler2, Molly S Kidder2, Tao Liu2, Juan Carlos Cardet1, Heng Chhay2, Chunli Feng2, Joshua A Boyce3.   

Abstract

BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is an inflammatory condition of the respiratory tract and is characterized by overproduction of leukotrienes (LT) and large numbers of circulating granulocyte-platelet complexes. LT production can be suppressed by prostaglandin E(2) (PGE(2)) and the cyclic AMP-dependent protein kinase A (PKA).
OBJECTIVE: To determine if PGE(2)-dependent control of LT production by granulocytes is dysregulated in AERD.
METHODS: Granulocytes from well-characterized patients with and without AERD were activated ex vivo and subjected to a range of functional and biochemical analyses.
RESULTS: Granulocytes from subjects with AERD generated more LTB4 and cysteinyl LTs than did granulocytes from controls with aspirin-tolerant asthma and controls without asthma. When compared with controls, granulocytes from subjects with AERD had comparable levels of EP(2) protein expression and PGE(2)-mediated cAMP accumulation, yet were resistant to PGE(2)-mediated suppression of LT generation. Percentages of platelet-adherent neutrophils correlated positively with LTB4 generation and inversely with responsiveness to PGE(2)-mediated suppression of LTB(4). The PKA inhibitor H89 potentiated LTB4 generation by control granulocytes but was inactive in granulocytes from individuals with AERD and had no effect on platelet P-selectin induction. Both tonic PKA activity and levels of PKA catalytic gamma subunit protein were significantly lower in granulocytes from individuals with AERD relative to those from controls.
CONCLUSIONS: Impaired granulocyte PKA function in AERD may lead to dysregulated control of 5-lipoxygenase activity by PGE(2), whereas adherent platelets lead to increased production of LTs, which contributes to the features of persistent respiratory tract inflammation and LT overproduction.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  AERD; Samter's triad; aspirin triad; aspirin-exacerbated respiratory disease; asthma; cyclic AMP; leukotriene; nonsteroidal anti-inflammatory drug; prostaglandin E(2); protein kinase A

Mesh:

Substances:

Year:  2014        PMID: 24486071      PMCID: PMC4040319          DOI: 10.1016/j.jaci.2013.12.1034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  49 in total

1.  Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13.

Authors:  John Trudeau; Haizhen Hu; Kazuyuki Chibana; Hong Wei Chu; Jay Y Westcott; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2006-05-02       Impact factor: 10.793

2.  The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1.

Authors:  Lena Svensson; Claes Dahlgren; Christine Wennerås
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

3.  The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.

Authors:  M P Berges-Gimeno; R A Simon; D D Stevenson
Journal:  Clin Exp Allergy       Date:  2002-10       Impact factor: 5.018

4.  Cyclic AMP-independent activation of protein kinase A by vasoactive peptides.

Authors:  N O Dulin; J Niu; D D Browning; R D Ye; T Voyno-Yasenetskaya
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

5.  Platelets are essential for leukocyte recruitment in allergic inflammation.

Authors:  Simon C Pitchford; Hiroshi Yano; Rebecca Lever; Yanira Riffo-Vasquez; Silvia Ciferri; Mark J Rose; Silvia Giannini; Stefania Momi; Domenico Spina; Brian O'connor; Paolo Gresele; Clive P Page
Journal:  J Allergy Clin Immunol       Date:  2003-07       Impact factor: 10.793

6.  Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes.

Authors:  C W Lee; R A Lewis; E J Corey; K F Austen
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

7.  Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.

Authors:  N A Soter; R A Lewis; E J Corey; K F Austen
Journal:  J Invest Dermatol       Date:  1983-02       Impact factor: 8.551

Review 8.  Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.

Authors:  Andrew Szczeklik; Donald D Stevenson
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

9.  Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523.

Authors:  Ming Luo; Sandra M Jones; Susan M Phare; Michael J Coffey; Marc Peters-Golden; Thomas G Brock
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

10.  Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.

Authors:  H Mita; N Higashi; M Taniguchi; A Higashi; K Akiyama
Journal:  Clin Exp Allergy       Date:  2004-08       Impact factor: 5.018

View more
  20 in total

1.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Anju T Peters; Annemarie G Hirsch; Cara M Nordberg; Brian S Schwartz; Dione G Mercer; Mahboobeh Mahdavinia; Leslie C Grammer; Kathryn E Hulse; Robert C Kern; Pedro Avila; Robert P Schleimer
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

2.  Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines.

Authors:  Taylor A Doherty; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2018-03-06       Impact factor: 10.793

3.  Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD).

Authors:  Arun Narayanankutty; Icela Palma-Lara; Gandhi Pavón-Romero; Gloria Pérez-Rubio; Ángel Camarena; Luis M Teran; Ramcés Falfán-Valencia
Journal:  Lung       Date:  2016-02-18       Impact factor: 2.584

Review 4.  Platelets in patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2015-06       Impact factor: 10.793

5.  Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.

Authors:  Katherine N Cahill; Benjamin A Raby; Xiaobo Zhou; Feng Guo; Derek Thibault; Andreas Baccarelli; Hyang-Min Byun; Neil Bhattacharyya; John W Steinke; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

6.  Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.

Authors:  Xin Feng; Madison K Ramsden; Julie Negri; Mary Grace Baker; Spencer C Payne; Larry Borish; John W Steinke
Journal:  J Allergy Clin Immunol       Date:  2016-06-14       Impact factor: 10.793

7.  Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.

Authors:  Tao Liu; Yoshihide Kanaoka; Nora A Barrett; Chunli Feng; Denise Garofalo; Juying Lai; Kathleen Buchheit; Neil Bhattacharya; Tanya M Laidlaw; Howard R Katz; Joshua A Boyce
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

8.  Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.

Authors:  Elina Jerschow; Zhen Ren; Golda Hudes; Marek Sanak; Esperanza Morales; Victor Schuster; Simon D Spivack; David Rosenstreich
Journal:  Ann Allergy Asthma Immunol       Date:  2016-01-25       Impact factor: 6.347

9.  Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.

Authors:  Katherine N Cahill; Jing Cui; Parul Kothari; Katherine Murphy; Benjamin A Raby; Joseph Singer; Elliot Israel; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 10.  Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease.

Authors:  Kellen J Cavagnero; Taylor A Doherty
Journal:  Ann Allergy Asthma Immunol       Date:  2020-09-17       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.